Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV
Abstract
This paper has been withdrawn.
Skip to main content
Browse
- Research Centers and Departments
- Conferences and Events
- Disciplines
- Student Work
- Open Educational Resources
For Authors
Scholarly Communication
- (435) 797-0816
Research Data
- 435-797-2632
- Research Data Management Services @ USU
